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etter to the Editortiology  of bronchopulmonary  infections  in Bulgarian  cystic
brosis patientsear Editor,
ystic ﬁbrosis (CF) is an autosomal recessive inherited dis-
rder  characterized by abnormal secretory function of all
xocrine  glands. Clinical symptoms vary with the severity of
he  disease and according to the organs involved, but the
ost  common ones are pathological lung changes mainly
resented as chronic infections. These bronchopulmonary
nfections (BPI) are the major reason for both progressive
ecreasing of lung function and mortality.
The aim of this study was  to explore and analyze the eti-
logical  structure of BPI in Bulgarian CF patients according to
he patient’s age and gender.
During  2006–2011 period we  examined 108 patients (46
emales  and 62 males), aged 5–27 years, with genetically
onﬁrmed CF disease. Sputum samples were  plated and incu-
ated  at 37 ◦C for 24–48 h. BPI pathogens were identiﬁed by a
BL  Crystal ID system (Becton Dickinson). From the sputum,
enomic  bacterial DNA was  extracted and ampliﬁed by PCR
mploying  two sequence-speciﬁc targets, namely (i) the Pseu-
omonas  aeruginosa exotoxin A locus, and (ii) the Burkholderia
epacia complex recA gene using speciﬁc primers and con-
itions  as previously described.1,2 Statistical analysis was
erformed by Student’s t-test.
The etiologic agents of BPI are shown in Fig. 1. The leading
athogens causing BPI were  P. aeruginosa and Staphylococcus
ureus, followed by Candida spp., Klebsiella–Enterobacter–Serratia
roup, and Haemophilus inﬂuenzae. Co-infection of 2 or 3
icroorganisms was found in 44 patients (40.7%).
The frequency of the infections caused by P. aeruginosa
57.4%) was  very close that reported by the USA Cystic Fibrosis
oundation in 2009–2010 (51.7%). On the contrary, the fre-
uency  of S. aureus (35.2%) is lower compared to those in the
SA  – 51.3% (2009) and 67.0% (2010). Our established frequency
f  B. cepacia complex (5.5%) was  slightly higher than in the USA
n  2009–2010 (2.7% and 2.5% respectively), whereas the 3.3%
f  Stenotrophomonas maltophilia was  lower (12.7% and 13.8%
espectively).3,4
Regarding P. aeruginosa we found that patients of 10-years
ld  and younger were  signiﬁcantly less colonized (42.1%) thanpatients  over 16 years of age (83.3%) [p < 0.01]. In the younger
patients  S. aureus was isolated in 42.1%, compared to 25%,
among  patients aged 16 years or more.  Candida spp. was  iso-
lated  in 21% of those aged less than 10 years and in 41.7% in
adolescent/adult age group (16+ years).
In comparison with data from the USA, the rate of coloniza-
tion  by P. aeruginosa abruptly increases from 25% at the age
of  6 years to 65% among 18 year-old patients, and up to 80%
in  those patients older than 25 years. Respiratory tract colo-
nization  with S. aureus (around 70% in those aged between 6
and 17 years) steadily increases up to the 10th year and then
slowly  decreases between the 11th and 17th year followed by
a signiﬁcant decrease after the age of 17 years.4
The prevalence of P. aeruginosa infections was  signif-
icantly higher in girls (73.9% vs. 45.2% among boys –
p  < 0.05). Likewise, S. aureus infections predominated among
females  (43.5%/29.0%) and so did Candida spp. infec-
tions (43.5%/19.4%). The frequency of BPI, caused by the
Klebsiella–Enterobacter–Serratia group of pathogens was  similar
in  both genders (8.7% in girls and 12.9% in boys).
Well documented by other authors gender difference in the
onset  of chronic infection by P. aeruginosa – average 1 year and
7  months earlier for the girls,5 could explain higher percentage
of  P. aeruginosa in girls compared to the boys of our results.
A  recently carried on survey of annual hospitalization
records of Scandinavian CF patients aiming to search for gen-
der  differences in clinical characteristics and treatment plans
revealed  a higher frequency of new chronic infection by P.
aeruginosa  in females (30.3%) compared to males (7.1%) in a
1-year  period. Furthermore, in adult female patients a higher
risk  for infections caused by P. aeruginosa and Burkholderia spp.
was  established.6
The current study conﬁrms the global trends of the leading
etiologic pathogens in the airways and the dynamic changes
found  in respiratory microbial ﬂora as the CF patients age
–  a considerable increase in P. aeruginosa colonization and
decrease  in S. aureus colonization after 16 years of age. Suc-
cessful  eradication of the initial and subsequent BPI in the
early  years of CF patients improves the quality of life and
survival  of these individuals.
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6Fig. 1 – Total etiology of BPI in Bulgarian CF patient
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